ATOS

ATOS

USD

Atossa Therapeutics Inc. Common Stock

$0.878-0.008 (-0.903%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$0.886

Máximo

$0.934

Mínimo

$0.870

Volumen

0.52M

Fundamentos de la Empresa

Capitalización de Mercado

113.4M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.69M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $0.55Actual $0.878Máximo $1.66

Noticias Relacionadas

Analyst Upgrades

Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $7.5

Ascendiant Capital analyst Edward Woo maintains Atossa Therapeutics with a Buy and raises the price target from $7.25 to $7.5.

Ver más
Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $7.5
Analyst Upgrades

Craig-Hallum Initiates Coverage On Atossa Therapeutics with Buy Rating, Announces Price Target of $4

Craig-Hallum analyst Albert Lowe initiates coverage on Atossa Therapeutics with a Buy rating and announces Price Target of $4.

Ver más
Craig-Hallum Initiates Coverage On Atossa Therapeutics with Buy Rating, Announces Price Target of $4
PR Newswire

Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for...

Ver más
Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.